Comparing Utility of First-Line Vasoactive Drugs in Pediatric Septic Shock

There have been many international consensus statements on the diagnosis and management of pediatric sepsis and septic shock during the past few decades. However, because of the complexity and variability in the presentation and natural course of the disease, specific recommendations regarding the ideal vasoactive agent remain controversial. Ventura et al used clinical and laboratory parameters to determine whether children with fluid-refractory septic shock would benefit more from a potent inotrope (i.e., epinephrine) than from dopamine.

Overall, the study suggested a significant benefit to using epinephrine as a first-line agent (compared to dopamine).

Read the full Concise Critical Appraisal by logging in to the SCCM eCommunity. Concise Critical Appraisal is a regular feature aimed at highlighting the best and most relevant literature from a variety of academic journals and encouraging discussion around recent studies and research.

eNewsletter Issue: